Shirley, NY (June 27, 2013) – Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:
Luitpold’s NY facility has undergone significant renovations and upgrades to meet enhanced quality standards and address observations made by the U.S. Food and Drug Administration (FDA). These renovations required cessation of manufacturing and affected Luitpold’s ability to release product. This has resulted in shortages in the marketplace. Luitpold has worked in recent months to optimally allocate inventory and manage the limited remaining supply, which has now been depleted.
Luitpold remains committed to resuming its manufacture and release of Adequan® products. We understand how critically important the Adequan® brands are to the health and well-being of the animals receiving treatment. The company’s latest expectations for reestablishing Adequan® supply to the market is estimated to be first quarter 2014 however, this hinges upon completion of a successful inspection by the FDA.
The company has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.
During this supply interruption, we strongly recommend Veterinarians work together with equine and canine owners and caregivers to evaluate and decide upon the safest and most effective alternative treatments.
Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
The United States Eventing Association (USEA) is thrilled to welcome back World Equestrian Brands as the Title Sponsor of the USEA Rider of the Year Leaderboard for 2021 and 2022. This year’s USEA Rider of the Year will be honored at the 2021 USEA Year-End Awards Ceremony held during the USEA Annual Meeting & Convention on Saturday, Dec. 11 at the Hyatt Regency Albuquerque in Albuquerque, New Mexico. World Equestrian Brands will generously provide the winner with a prize of $500 in value. Next year, the USEA Rider of the Year will be recognized during the 2022 USEA Annual Meeting & Convention which will take place in Savannah, Georgia on Dec. 7-11, 2022.
What better way to draw the competition season to a close than with a win in a USEA Classic Series division? Three competitors did just that on the weekend of November 17-18 at the Fresno Horse Park in Fresno, California.
The United States Eventing Association (USEA) is pleased to announce the renewed partnership with Rebecca Farm. Rebecca Farm will return as a Gold Level Sponsor of the 2021 USEA Annual Meeting & Convention and will be the exclusive sponsor for the Annual Meeting continental breakfast. This year’s Annual Meeting & Convention will take place at the Hyatt Regency Albuquerque in Albuquerque, New Mexico on December 9-12, 2021.
With the new competition season kicking off officially on December 1, it’s time to brush up on the USEF Rules For Eventing ! There are five new rules and amendments that will take effect at the start of the new season regarding competition approvals, officials, and more. To access the full 2022 USEF Rulebook, click here.